Clinical trial
A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for…
NCT00146380 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00146380 |
|---|---|
| Title | A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding |
| Official title | A Phase II Open Label Clinical Trial of Maternal Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Maximal Reduction of Mother-to-child HIV Transmission in Resource-limited Settings Among Breastfeeding Populations |
| Acronym | KiBS |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral, Drug |
| Interventions | Zidovudine/Lamivudine and either Nevirapine or Nelfinavir, Breastfeeding for 6 months postpartum |
| Enrollment | 520 |
| Start date | Jul 1, 2003 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2013 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 15, 2025 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: